NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.



The Good, The Bad And The Deadly

By Irish Pharmacist - 06th Jun 2022

A Clinical Overview Of The Different Types Of Cholesterol And Their Impact On Human Physiology.

Cholesterol is a lipid (fat). It is manufactured by the liver from the fatty foods that we eat, and plays a vital part in allowing the body to function normally. Cholesterol is present in the membrane (outer layer) of every cell in the body. It insulates nerve fibres, and is an essential building block for hormones, such as the sex hormones, and the hormones of the adrenal cortex. It also enables the body to produce bile salts. 

Cholesterol is carried in the blood by molecules called lipoproteins. There are several different lipoproteins, but the three main types are: 

  • Low density lipoprotein (LDL). This is often known as ‘bad cholesterol’ and is thought to promote arterial disease. It carries cholesterol from the liver to the cells and can cause a harmful build-up if there is too much for the cells to use. Normally, the blood contains about 70 per cent of LDL, but the level will vary from person-to-person. Recommended LDL level is below 3.37mmol/l. 
  • High-density lipoprotein (HDL). This is often referred to as ‘good cholesterol’ and is thought to prevent arterial disease. It takes cholesterol away from the cells and back to the liver, where it is either broken down, or is passed from the body as a waste product. Recommended LDL range is 1.45-to-4mmol/l. 
  • Triglycerides are another type of fatty substance present in the blood. They are found in dairy products, meat, and cooking oils. Triglycerides are also produced by the liver. Those who are overweight, have a diet that is high in fatty or sugary foods, or drink a large amount of alcohol, have an increased risk of having a high triglyceride level. Recommended triglyceride level is below 1.71mmol/.l 

The amount of cholesterol present in the blood can range from 3.6-to- 7.8mmol/litre. A level above 6mmol/litre is considered high, and a risk factor for arterial disease. A total cholesterol level of below 5.2mmol/litre is recommended to prevent heart disease. 

Evidence strongly indicates that high cholesterol levels can cause narrowing of the arteries (atherosclerosis), heart attacks, and strokes. The risk of coronary heart disease also rises as blood cholesterol levels increase. If other risk factors, such as high blood pressure and smoking, are present, the risk increases even more. 


High cholesterol is not a disease in itself, but it is linked to serious conditions, such as cardiovascular conditions (disease of the heart and blood vessels), angina, stroke, and mini-stroke, known as transient ischemic attack (TIA). A high level of cholesterol in the blood, together with a high level of triglycerides, can increase the risk of developing coronary heart disease. 

A total cholesterol level of below 5.2mmol/litre is recommended to prevent heart disease

Coronary heart disease is caused by narrowing of the arteries that supply the heart with blood. This narrowing of the arteries is called atherosclerosis. Fatty deposits, such as cholesterol, cellular waste products, calcium and other substances, build up in the inner lining of an artery. This build-up, known as plaque, usually affects small- and medium-sized arteries. The flow of blood through the arteries is restricted, as the inside diameter is reduced. Blood clots, which often happen in the coronary arteries during a heart attack, are more likely to develop when arterial walls are roughened by the build-up of fatty deposits. 

A high cholesterol level may only be revealed with symptoms of atherosclerosis. These can include: 

  • Angina, caused by narrowed coronary arteries in the heart. 
  • Leg pain on exercising, due to narrowing of the arteries that supply the lower limbs. 
  • Blood clots and ruptured blood vessels, which can result in a stroke or mini stroke (TIA). 
  • Ruptured plaques can lead to a blood clot forming in one of the arteries delivering blood to the heart (coronary thrombosis), and may lead to heart failure if a significant amount of heart muscle is damaged. 
  • Thick yellow patches (xanthomas) around the eyes or elsewhere on the skin. These are cholesterol deposits and can often be seen in people with inherited or familial cholesterol (where close family members have a history of high cholesterol). 


A number of different factors can contribute to high blood cholesterol: 

1. Lifestyle risk factors 

There are a number of preventable lifestyle-related risk factors that can increase risk of developing high blood cholesterol. 

They include: 

  • Unhealthy diet — some foods contain cholesterol (known as dietary cholesterol), for example, liver, kidneys and eggs. However, dietary cholesterol has little effect on blood cholesterol. More important is the amount of saturated fat in the diet. Foods that are high in saturated fat include red meat, meat pies, sausages, hard cheese, butter and lard, pastry, cakes and biscuits, and cream, such as soured cream and crème fraîche, 
  • Lack of exercise or physical activity — this can increase the level of bad cholesterol (LDL), and decrease the level of good cholesterol (HDL), 
  • Obesity — being overweight means increased risk of high LDL and a decreased level of HDL, increasing overall blood cholesterol level. 
  • Smoking. 
  • Drinking excessive amounts of alcohol — the recommended amount is three-to-four units a day for men, and two-to-three units a day for women. 

2. Treatable risk factors 

  • Hypertension (high blood pressure). 
  • Diabetes. 
  • A high triglyceride blood level. 
  • Medical conditions, such as kidney and liver diseases, and an under-active thyroid gland. 

3. Fixed risk factors 

  • A family history of heart disease or stroke — it is more likely to have high cholesterol if one has a close male relative (father or brother) aged under 55, or a female relative (mother or sister) aged under 65, who has been affected by coronary heart disease or stroke. 
  • A family history of cholesterol-related conditions, for example, if a close relative, such as a parent, brother, or sister has familial hypercholesterolaemia, or combined hyperlipidaemia. 
  • Being male — men are more at risk of having high blood cholesterol than women. 
  • Age — the older we get, the greater the likelihood of developing atherosclerosis. 
  • Early menopause in women. 
  • Ethnic group people who are of 

Indian, Pakistani, Bangladeshi, or Sri Lankan descent have an increased risk of high blood cholesterol. 

If a patient has a fixed risk factor (or several fixed risk factors), it is even more important to take steps to address any lifestyle or treatable risk factors. 


According to research published in the Journal of Epidemiology and Community Health in 2006, changes in three classic cardiovascular risk factors (smoking, cholesterol, and blood pressure) contributed to a 61.9 per cent decrease of total coronary heart disease (CHD) mortality in Ireland between 1985 to 2000; this was consistent with studies in other developed countries. In Ireland in 2000, heart disease was the leading cause of death, being responsible for 41 per cent of all deaths. In 2020, CSO figures show that diseases of the circulatory system (which includes CHD) were responsible for 26.3 per cent of all deaths. Smoking reduction is a big factor, but better diagnosis of cholesterol and hypertension along with better and earlier treatment interventions is a big factor in this drop in deaths from heart disease. The better availability and affordability of statins in controlling cholesterol is seen as a major factor in this reduction of deaths from CHD. 


To measure cholesterol, a simple blood test is often carried out. Before the test is done, it is best not to eat for 12 hours (usually including night-time when asleep). This ensures that all food is completely digested and will not affect the outcome of the test. A GP, practice nurse or pharmacist can carry out the blood test, and will take a sample either using a needle and a syringe, or by pricking a finger. 

The blood sample that is taken during the blood test will be used to determine the amount of LDL (‘bad’ cholesterol), HDL (‘good’ cholesterol), and triglycerides in blood. Blood cholesterol is measured in units called millimoles per litre of blood (mmol/litre). It is recommended to have a total blood cholesterol level of less than 5mmol/litre, and an LDL cholesterol level of under 3mmol/litre. 

Anyone can have their blood cholesterol level tested, but it is particularly important to have it checked if: 

  • Aged over 40. 
  • A family history of cardiovascular disease, for example, if one’s father or brother developed heart disease, or had a heart attack, or a stroke before the age of 55, or if one’s mother or sister had these conditions before the age of 65. 
  • A close family member has a cholesterol-related condition, such as familial hypercholesterolemia, or combined hyperlipidaemia. 
  • Are overweight or obese. 
  • Have high blood pressure (hypertension). 
  • Have a medical condition, such as a kidney condition, an under-active thyroid gland, or acute inflammation of the pancreas (acute pancreatitis). This is because these conditions can cause an increased level of cholesterol. 

In assessing risk of cardiovascular disease, heart attack, or stroke, cholesterol ratio should not be taken on its own. Lifestyle factors should also be taken into consideration. For example: 

  • Smoking. 
  • Diet. 
  • BMI (body mass index — weight in relation to height). 
  • Treatable risk factors, such as high blood pressure (hypertension) and diabetes. 
  • Fixed risk factors, such as age, sex, and ethnicity. 


High cholesterol levels can be made worse by any other medical conditions. Medical problems such as an underactive thyroid gland, an overactive pituitary gland, liver disease, or kidney failure, can all contribute to high cholesterol levels. 

Some people have inherited disorders, such as familial hypercholesterolemia, or combined hyperlipidaemia, that prevent fats from being used properly and eliminated from the body. This allows the level of cholesterol to build up in the blood. 

The major complications of raised blood cholesterol are heart attacks, strokes and arterial disease. The risks of all of these are increased if the patient is/has: 

  • Overweight. 
  • A smoker. 
  • Has high blood pressure. 
  • Strong family history of these conditions. 
  • Diabetic. 


Patients can prevent high blood cholesterol by eating a healthy, balanced diet that is low in saturated fat. Including a small amount of unsaturated fats in the diet is a healthy choice, as this type of fat can actually reduce cholesterol levels. Current thinking is that the traditional Mediterranean diet, with its emphasis on raw olive oil in many foods and low animal fat content, is effective in ensuring cardiovascular health. Foods high in unsaturated fats include: 

  • Oily fish. 
  • Avocados. 
  • Nuts and seeds. 
  • Sunflower, rapeseed, and olive oil. 
  • Vegetable oils. 


When diagnosed with high cholesterol, the first method of treatment will usually involve making dietary changes (adopting a low-fat diet), and ensuring plenty of regular exercise. After a few months, if cholesterol level has not dropped, advice may be to take cholesterol-lowering medication. 


Ensuring a healthy diet by changing to one that is low in saturated fats can reduce the level of LDL or bad cholesterol. If in a high-risk category of getting cardiovascular disease, altering diet will not lower risk sufficiently. A healthy diet includes foods from all different food groups, including carbohydrates (cereals, wholegrain bread, potato, rice, pasta), proteins (for example, from lean meat, such as chicken and oily fish, like mackerel or sardines), and fats (varieties that are unsaturated, such as low-fat mono- or poly-unsaturated spreads, and vegetable or sunflower oil). Eat at least five portions of a variety of different fruit and vegetables daily.


There are several different types of cholesterol-lowering medication, which work in different ways. Commonly-prescribed medications include: 

  • Statins (HMG-CoA reductase inhibitors). Statins, such as simvastatin and atorvastatin, work by blocking the enzyme (chemical) in the liver that is needed for making cholesterol. Statins are used to reduce cholesterol to less than 4mmol/l and LDL cholesterol to less than 2mmol/l. They are therefore useful in preventing and treating atherosclerosis, which can cause chest pain, heart attacks, and strokes. Statins sometimes have mild side-effects which can include constipation, diarrhoea, headaches, and abdominal pain. 
  • Aspirin may be recommended, depending on age and several other factors. A low daily dose of aspirin can prevent blood clots from forming. (Children under 16 years should not take aspirin.) 
  • Niacin is a B vitamin that is found in foods and in multivitamin supplements. In high doses, available by prescription, niacin lowers LDL cholesterol and raises HDL cholesterol. Minor side-effects include flushing or tingling skin, itching, and headaches. More research is needed to prove the effectiveness of niacins in reducing cholesterol. 
  • Other medications, such as cholesterol absorption inhibitors (ezetimibe), and bile-acid sequestrants (ie, cholestyramine), are sometimes used to treat high cholesterol. However, bile-acid sequestrants may be less effective than other forms of treatment and have more side-effects. PCSK9 inhibitors are a new type of cholesterol medication for resistantly high cholesterol administered in subcutaneous form either two-weekly or monthly. 

If the patient has high blood pressure (hypertension), the GP may also prescribe medication to lower it. 

Table 1: Statin Intensity Table, courtesy of NHS England (Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD).


Statins are world’s most prescribed drugs and are effective medications in reducing cholesterol in most patients. There are several types of statins on the market, but they all work in the same way. Examples of statins available on the market are Atorvastatin, Pravastatin, Rosuvastatin, Simvastatin and Fluvastatin. 

Statins are only available with a doctor’s prescription in Ireland. Since 2004, simvastatin 10mg has been available over the counter in pharmacies in the UK; however, they are sold under strict guidelines under the supervision of the pharmacist and the patient must meet specific criteria, ie, patients targeted are those at a 10-to-15 per cent risk of an event in 10 years. 

Clinical trials show that statins are very effective at reducing cholesterol and hence heart disease. Statins are one of the major reasons for the significant fall in the death rate from heart disease in Ireland since they were first launched over 30 years ago. Statins work by blocking the enzyme HMG-CoA reductase, which plays an important role in the production of cholesterol in the liver. They are therefore useful in preventing and treating atherosclerosis, which can cause chest pain, heart attacks, strokes and cardiac deaths. 

Most statins must be taken at night, as most cholesterol is made while we sleep. The only statin which does not have to be taken at night is atorvastatin, which can be taken morning or night. Statins are more effective in reducing LDL cholesterol than other cholesterol medication. 

Table 2: LDL-C concentrations above which PCSK9s are recommended by NICE 


A study published in the British Medical Journal in 2003 showed that on average, statins reduce LDL cholesterol by 1.8mmol/litre. This resulted in a 60 per cent reduction in the risk of cardiovascular events such as heart attacks, clots, and sudden cardiac death and a 17 per cent reduction in the risk of stroke. 


No major study has shown one statin to be significantly more effective than others. The CURVES study in America in 1998 indicated that atorvastatin was more effective than other statins at lowering cholesterol and this was one of the major reasons that atorvastatin became the most prescribed statin in the intervening years and Lipitor became a ‘blockbuster’ drug for Pfizer. However, the effectiveness of atorvastatin over other statins has since been somewhat discounted; for example, another study published in the American Heart Journal in 2006 showed that there was no significant difference between atorvastatin and other statins (simvasatin and pravastatin) at reducing heart disease.

In Ireland, over 20 per cent of adults are at risk of coronary heart disease due to high cholesterol

A study published in the International Journal of Endocrinology and Metabolism in 2017 (study was on an Asian population) indicated effects of statins on lipid profile are dose-dependent and showed that rosuvastatin had the best effect on lipid profile. However, overall, studies indicate there is no real reason to recommend one statin over another. Atorvastatin has the benefit that it can be taken in the morning. The HSE recommends simvastatin as first choice on State PCRS schemes for cost reasons; however, all generic statins have become similarly priced in Ireland in recent years with the advent of reference pricing by the HSE. 


In Ireland, over 20 per cent of adults are at risk of coronary heart disease due to high cholesterol. There is some controversy as to who should be prescribed statins. The general guideline for people who have no previous heart problems is that they should be used if cholesterol is high (over 6mmol/litre) and there is a cardiovascular risk of greater than 20 per cent over the next 10 years. Cardiovascular risk over 10 years is risk of having any cardiovascular event such as stroke or heart attack over the next 10 years. It depends on many factors, such as age, sex, weight, blood pressure, cholesterol, family history of heart disease, and whether a smoker or are diabetic. For those who have already suffered a cardiovascular event such as a stroke, statins are recommended if total cholesterol is over 3.5mmol/l. Guidelines state that they should be considered in all diabetic patients over 40. Statins are very frequently prescribed in the elderly, as elderly patients generally have a higher risk of heart disease. 


Like all medication, statins can cause side-effects. The most serious side-effect of statins is a muscle complaint called myalgia. It is characterised by muscle pain and weakness. If it occurs, the statin should be stopped, as it can lead to a potentially fatal condition called rhabdomyolysis. It is estimated that one-in-1,000 people using statins may suffer from myalgia and one-in-10,000 may suffer from rhabdomyolysis. Patients must report to their doctor immediately if suffering from muscle pain, tenderness or weakness while taking a statin. The myalgia from statins is reversible if the statin is stopped promptly. 

Statins can also raise liver enzymes, which can lead to liver problems. It is very important to do a liver function test for those starting statins. Current guidelines are to get a liver function test before starting a statin, three months after starting, and again after 12 months. 

Gastrointestinal effects (nausea, indigestion, constipation, diarrhoea, and flatulence) are the most common side-effects of statins. Headache, dizziness, and rash occur less frequently. Sleep disturbance can occur, although it seems to be more of a problem with simvastatin and atorvastatin. Most people who take statins have no problems and they are proven to save lives by preventing heart disease. 


Statins can reduce naturally-occurring coenzyme Q10 in the body. Co-enzyme Q10 has a role in muscle cell energy production, so some studies have proposed that a co-enzyme Q10 supplement could reduce the risk of muscle-related side-effects. However, scientific studies to determine how effective coenzyme Q10 is in reducing statin-related muscle pain have mixed results. Some studies show a benefit, while other studies show no effect. So, if a coenzyme Q10 has rarely any side-effects, a trial to determine if it helps any potential muscle problems would do no harm. 


Statins are less effective than fibrates in reducing triglycerides. Fibrates are another type of cholesterol-lowering medicines but are rarely used nowadays mainly due to gastrointestinal side-effects such as nausea, ie, gemfibrozil (Lopid). Other non-statin drugs used to lower cholesterol include ezetimibe, which reduces the absorption of cholesterol and is used instead of a statin if a statin is not tolerated, or in addition to a statin if a statin is not reducing cholesterol sufficiently. 


PCSK9 inhibitors are a new class of cholesterol-lowering drugs that show excellent results in bringing down non- HDL levels in certain high-risk patients. They work by blocking a protein called PCSK9, which has a role in moderating cholesterol levels in the blood. 

In June 2016, NICE recommended two PCSK9 inhibitor drugs for the NHS — Repatha (evolocumab) and Praluent (alirocumab) for treating certain patients with primary hypercholesterolaemia or mixed dyslipidaemia who cannot tolerate statins or who have reached the maximum statin dose without sufficient cholesterol reduction. 

Researchers on the FOURIER trial investigating the effectiveness of evolocumab in the UK described it as “probably the most important trial result of a cholesterol-lowering drug in over 20 years”. Results showed a 59 per cent drop in cholesterol levels compared to placebo and a 15 per cent lower risk of cardiovascular events. 

According to NICE, additional lipid-lowering therapies should be considered if: 

1. Target LDL-C level is not attained on statins alone, add ezetimibe and trial for at least three months. 

2. If target LDL-C level is still not attained, consider PCSK9 inhibitor, subject to NICE criteria in Table 1, in addition to existing lipid-lowering therapy. 


Repatha (evolocumab) and Praluent (alirocumab) are both licensed in Ireland. Repatha (evolocumab), for example, is a 140mg solution for injection in Sureclick pre-filled pen and is available under the High-Tech Scheme in Ireland since 1 July 2019. Specific criteria must be satisfied for a patient to be recommended for reimbursement of Repatha under the High-Tech arrangement. 

The prescribing of Repatha under the High-Tech Scheme is confined to designated clinicians who have agreed to the terms of the HSE-Managed Access Protocol and have been approved by the HSE-Medicines Management Programme. The clinician must submit an online application for individual reimbursement approval for each patient. Applications for individual reimbursement approval will only be considered from approved clinicians. Pharmacists like myself have noticed a small number of high-risk patients with very stubbornly high cholesterol being prescribed PCSK9 inhibitors in the last two years under the High- Tech scheme. ? 

References available upon request 

Disclaimer: Brands mentioned in this article are meant as examples only and not meant as preference to other brands.


Written and researched by Eamonn Brady (MPSI), owner of Whelehans Pharmacies in Mullingar Tel 04493 34591 (Pearse St) or 04493 10266 (Clonmore). www.whelehans. inet. Eamonn specialises in the supply of medicines and training needs of nursing homes throughout Ireland. Email 







Latest Issue

Irish Pharmacist May 2024

Irish Pharmacist May 2024. Volume 25 | Issue 5 | May 2024. Read the latest issue of Irish Pharmacist here…


OTC Update Spring 2024

Spring 2024 | Issue 1 | Volume 18. Read the latest issue of OTC Update here.